Geneva, July 14 -- International Clinical Trials Registry received information related to the study (ISRCTN61644835) titled 'Add-on benefit of cerebrolysin to acute stroke patients given recombinant tissue plasminogen activator' on July 3.
Study Type: Interventional
Study Design:
Randomized open-label multi-center prospective cohort study (Efficacy)
Primary Sponsor: Baguio General Hospital and Medical Center
Condition:
Acute ischemic stroke after intravenous thrombolysis
Circulatory System
Intervention:
Patients will be randomized using the research randomizer to either the treatment group or the control group. The research randomizer (randomizer.org) is a free online software used to generate random numbers or assign participant...